Vial-to-Pen: Community Pharmacists Converting Insulin Regimens

Objective: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. Methods: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contact...

Full description

Bibliographic Details
Main Authors: Ashley Hannings, Natasha Michaels, Debbie Hiller, Macary W Marciniak, Stefanie Ferreri
Format: Article
Language:English
Published: University of Minnesota Libraries Publishing 2019-07-01
Series:INNOVATIONS in Pharmacy
Subjects:
Online Access:https://pubs.lib.umn.edu/index.php/innovations/article/view/939
_version_ 1818645903730278400
author Ashley Hannings
Natasha Michaels
Debbie Hiller
Macary W Marciniak
Stefanie Ferreri
author_facet Ashley Hannings
Natasha Michaels
Debbie Hiller
Macary W Marciniak
Stefanie Ferreri
author_sort Ashley Hannings
collection DOAJ
description Objective: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. Methods: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted by community-based pharmacists during a five-month period and were informed of the availability and potential benefits of insulin pen delivery systems (IPDS). If the patient agreed to the switch, the pharmacist contacted the prescriber to obtain a new prescription. Prescription refill records were tracked for six months post-intervention to determine whether patients who were converted remained on the IPDS.  Results: The overall vial-to-pen conversion success rate was 26% out of 121 potential conversions. In addition, 52% of patients reached were willing to switch and prescribers approved 71% of the recommendations to switch from vial-to-pen. Of the prescriptions successfully converted to an IPDS, 84% of prescriptions were still dispensed as pen products six months following the conversion.  Conclusion: Community-based pharmacists can serve as a resource to provide education on insulin delivery options and increase use of IPDS in patients with diabetes.  Treatment of Human Subjects: IRB review/approval required and obtained   Article Type: Original Research
first_indexed 2024-12-17T00:38:09Z
format Article
id doaj.art-e0b3c510572545999c679ef47201c671
institution Directory Open Access Journal
issn 2155-0417
language English
last_indexed 2024-12-17T00:38:09Z
publishDate 2019-07-01
publisher University of Minnesota Libraries Publishing
record_format Article
series INNOVATIONS in Pharmacy
spelling doaj.art-e0b3c510572545999c679ef47201c6712022-12-21T22:10:06ZengUniversity of Minnesota Libraries PublishingINNOVATIONS in Pharmacy2155-04172019-07-0110310.24926/iip.v10i3.939Vial-to-Pen: Community Pharmacists Converting Insulin RegimensAshley Hannings0Natasha Michaels1Debbie Hiller2Macary W Marciniak3Stefanie Ferreri4University of Georgia College of PharmacySona Pharmacy + ClinicBlueCross BlueShield of North CarolinaUNC Eshelman School of PharmacyUNC Eshelman School of PharmacyObjective: To describe a vial-to-pen conversion program driven by community-based pharmacists and determine conversion success rate. Methods: A report based on prescription claims was generated and identified 200 prescriptions filled for an insulin vial product and syringes. Patients were contacted by community-based pharmacists during a five-month period and were informed of the availability and potential benefits of insulin pen delivery systems (IPDS). If the patient agreed to the switch, the pharmacist contacted the prescriber to obtain a new prescription. Prescription refill records were tracked for six months post-intervention to determine whether patients who were converted remained on the IPDS.  Results: The overall vial-to-pen conversion success rate was 26% out of 121 potential conversions. In addition, 52% of patients reached were willing to switch and prescribers approved 71% of the recommendations to switch from vial-to-pen. Of the prescriptions successfully converted to an IPDS, 84% of prescriptions were still dispensed as pen products six months following the conversion.  Conclusion: Community-based pharmacists can serve as a resource to provide education on insulin delivery options and increase use of IPDS in patients with diabetes.  Treatment of Human Subjects: IRB review/approval required and obtained   Article Type: Original Researchhttps://pubs.lib.umn.edu/index.php/innovations/article/view/939community pharmacyinsulin administrationinsulin pen delivery systemsinsulin vialinsulin syringe
spellingShingle Ashley Hannings
Natasha Michaels
Debbie Hiller
Macary W Marciniak
Stefanie Ferreri
Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
INNOVATIONS in Pharmacy
community pharmacy
insulin administration
insulin pen delivery systems
insulin vial
insulin syringe
title Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
title_full Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
title_fullStr Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
title_full_unstemmed Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
title_short Vial-to-Pen: Community Pharmacists Converting Insulin Regimens
title_sort vial to pen community pharmacists converting insulin regimens
topic community pharmacy
insulin administration
insulin pen delivery systems
insulin vial
insulin syringe
url https://pubs.lib.umn.edu/index.php/innovations/article/view/939
work_keys_str_mv AT ashleyhannings vialtopencommunitypharmacistsconvertinginsulinregimens
AT natashamichaels vialtopencommunitypharmacistsconvertinginsulinregimens
AT debbiehiller vialtopencommunitypharmacistsconvertinginsulinregimens
AT macarywmarciniak vialtopencommunitypharmacistsconvertinginsulinregimens
AT stefanieferreri vialtopencommunitypharmacistsconvertinginsulinregimens